Belgium· BE-AMP-SAM123706-00
Isoprinosine 500 mg
A inosine pranobex product containing inosine pranobex, registered in Belgium by Sanofi Belgium. The same ATC class is registered in 7 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Inosine pranobex is registered in 7 of 19 countries.
Countries holding a registration under ATC J05AX05 (inosine pranobex), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Inosine pranobex · ATC J05AX05
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Ireland
- Japan
- Norwayprice
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Inosine Pranobex
- Manufacturer
- Sanofi Belgium
- Country
- Belgium (BE)
- ATC code
- J05AX05
- ATC class
- Inosine pranobex
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0854364
- be_apb0726851
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inosine pranobex in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAkvirPolfarmex S.A.
- CzechiaISOPRINOSINEEwopharma International, s.r.o., Bratislava
- NorwayImunovirNewport Pharmaceuticals Ltd
- CanadaIMUNOVIRKORA HEALTHCARE
- Japanイノシンプラノベクス持田製薬
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Pranosine Forte, Аквир С Вкус На Ягода
- Czechia · Isoprinosine
- United Kingdom (Northern Ireland) · Imunovir
- Hungary · Inosine Pranobex Q Pharma Kft., Isoprinosine
- Ireland · Imunovir
- Lithuania · Isoprinosine
- Latvia · Isoprinosine
- Poland · Akvir, Akvir Forte O Smaku Truskawkowym
- Romania · Groprinosin, Inovira
- Slovakia · Inomed, Isoprinosine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2033a384-68b6-4705-a3c9-0aec43113cb6 GET /v1/drugs/2033a384-68b6-4705-a3c9-0aec43113cb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Isoprinosine 500 mg",
"name_fr": "Isoprinosine 500 mg",
"name_nl": "Isoprinosine 500 mg",
"amp_code": "SAM123706-00",
"strengths": [
"500.0000",
"500.0000"
],
"pack_count": 1,
"substances": [
"Inosine Pranobex"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Inosine Pranobex",
"authorisation_numbers": [
"BE123706"
]
}See everything about inosine pranobex.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.